KOMBIGLYZE XR 5 mg/1 (Saxagliptin and Metformin Hydrochloride TABLET, FILM COATED, EXTENDED RELEASE) 5 mg/1

KOMBIGLYZE XR 5 mg/1 combines saxagliptin and metformin hydrochloride for extended-release oral administration. This medication is designed to help manage certain health conditions related to blood sugar levels. Learn more about its uses and effects.

Strength

5 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0310-6135-30)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KOMBIGLYZE XR 5 mg/1 is a combination of saxagliptin and metformin hydrochloride, commonly used to help manage blood sugar levels in adults. This extended-release tablet is often prescribed as part of a treatment plan for conditions related to glucose regulation. It works by improving the way your body processes sugar, making it a useful tool for those who need additional support beyond diet and exercise.

Side Effects

Common effects of KOMBIGLYZE XR 5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

KOMBIGLYZE XR 5 mg/1 should be taken exactly as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

KOMBIGLYZE XR 5 mg/1 may interact with certain medications, including those that affect kidney function or other blood sugar-lowering drugs. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol consumption should be limited while taking this medication, as it can increase the risk of side effects.

Frequently Asked Questions

KOMBIGLYZE XR 5 mg/1 is used to help manage blood sugar levels in adults, often as part of a treatment plan for conditions related to glucose regulation.

KOMBIGLYZE XR 5 mg/1 should be taken orally, exactly as directed by your healthcare provider. It is an extended-release tablet, so it should not be crushed or chewed.

Common side effects may include gastrointestinal discomfort, nausea, diarrhea, headaches, or dizziness. These effects are usually mild and temporary.

It is advisable to limit alcohol consumption while taking KOMBIGLYZE XR 5 mg/1, as it can increase the risk of side effects.

KOMBIGLYZE XR 5 mg/1 should be stored at room temperature, away from moisture and heat, in its original packaging.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.